A webinar for World Antimicrobial resistance Awareness Week (WAAW 2023)
This webinar will present and discuss 2 new WHO Enhanced Gonococcal AMR Surveillance Programme (EGASP) technical products, and share latest AMR information related to sexually transmitted infections.
- EGASP: Surveillance report 2022: A surveillance report for EGASP data up to December 2022, from 4 countries.
- EGASP: supplementary protocols: a compilation of three sub-protocols of the EGASP on the extragenital sampling, the treatment failure cases and the whole genomic sequencing framework.
Date and time
Thursday, 23 November 2023 – 13:00–14:30 CET
Background
Sexually transmitted infections (STIs) bear a great risk of developing antimicrobial resistance (AMR). There is widespread resistance to most medicines used to treat Neisseria gonorrhoeae in many parts of the world. Other STI pathogens with potential AMR include Mycoplasma genitalium and Trichomonas vaginalis. The development of AMR is a global challenge.
The Global Health Sector Strategies on HIV, viral hepatitis and STIs for 2022-2030 have set a framework for countries to strengthen and expand surveillance and monitoring of treatment failures and participate in building regional networks of laboratories to perform gonococcal culture and antimicrobial susceptibility testing. Many countries report on gonococcal routine and/or enhanced gonococcal-AMR surveillance.
WHO’s department of Global HIV, Hepatitis and STIs Programmes (HHS) will participate in the global annual campaign to raise global awareness and understanding on AMR in STIs. This year’s campaign is entitled “Preventing Antimicrobial Resistance Together”.